• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec2
Hengrui Medicine Initiates Share Repurchase Plan
08:46
Hengrui Medicine's Remimazolam Trometamol Injection Marketing Authorization Application Accepted by NMPA
08:45
Dec1
GIC Private Limited Increases Stake in Hengrui Medicine to 23.03%
12:32
Nov28
Nomura Reiterates Buy Rating on WuXi AppTec, Raises Target Price to HKD132.8
03:55
Nov27
Hengrui Medicine Obtains Clinical Trial Approval Notices for Multiple Drugs
09:03
Hengrui Medicine Reaches $12.5 Billion Deal With GSK
05:21